TEDIRO
TEDIRO builds the CE-marked THERY mobile robot platform and gait-training applications (THERY UAG, THERY GO) that enable autonomous, AI-guided physiotherapy for hospitals, rehabilitation clinics, and nursing homes across the EU.
- Company typePrivate
- Founded2021
- HeadquartersIlmenau, Germany
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What TEDIRO does
TEDIRO Healthcare Robotics GmbH is a German medical robotics company founded in 2020-2021 as a spin-out from MetraLabs and Technische Universität Ilmenau, headquartered in Ilmenau with an additional office in Leipzig. The company develops and sells the THERY mobile robot platform, a CE-marked, autonomously navigating medical device (manufactured by MetraLabs using proprietary CogniDrive SLAM navigation) that supports multiple therapeutic software applications for gait training in clinical and care settings. The first application, THERY UAG, is CE marked under EU MDR and provides camera-based motion-capture gait analysis (32 joint/support points, 18 gait parameters at 30 fps) with real-time corrective feedback for patients training with forearm crutches after orthopedic surgery. A second application, THERY GO, extends the platform to assistive-device-independent gait training for nursing-home and rehabilitation use cases. A cloud-based Therapy Management System handles scheduling, patient identification, training plan creation, and automated documentation export to hospital IT systems, with GDPR-compliant German server infrastructure.
The business model combines capital-equipment hardware sales (THERY robot) with recurring software subscriptions (therapeutic applications and cloud management platform) and professional services for implementation and training, sold through a direct enterprise sales motion to hospitals, rehabilitation clinics, and nursing homes primarily in Germany and the broader EU. The company holds ISO 13485:2018 certification (surveillance audit passed January 2026), two pending patent applications, and has secured approximately EUR 1 million in seed funding (September 2021) led by bm-t with participation from MBG Thüringen and former Helios Kliniken CEO Olaf Jedersberger, supplemented by EU H2020 and regional R&D grants. Named reference customers include BG Klinikum Bergmannstrost Halle and Waldkliniken Eisenberg, the latter also serving as primary clinical development partner for the underlying gait analysis algorithms.
TEDIRO firmographics
Firmographics- Name
- TEDIRO
- Legal name
- TEDIRO Healthcare Robotics GmbH
- Website
- https://tediro.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- TEDIRO builds the CE-marked THERY mobile robot platform and gait-training applications (THERY UAG, THERY GO) that enable autonomous, AI-guided physiotherapy for hospitals, rehabilitation clinics, and nursing homes across the EU.
- Ownership category
- akta.pro rank
TEDIRO industry classification
Industry- Product category
- Medical Rehabilitation Robotics
- NAICS
- Offices of Physical, Occupational and Speech Therapists, and Audiologists (62134)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
- akta.pro primary industry
- Healthcare & Assistive Robotics (HDAAAIAC)
- akta.pro secondary industries
- Digital Rehabilitation & Physical Therapy Therapeutics (HLACANAJ), Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices) (HLAHAMAG), Human-Robot Interaction & Teleoperation Systems (HDAAAIAM)
Keywords
Where TEDIRO is headquartered
LocationHeadquarters
- HQ city
- Ilmenau
- HQ country
- Germany
- HQ region
- Europe
Offices2 records
Markets served
TEDIRO business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales
Revenue model
- Robot Hardware Sales: Sale of the THERY robot platform (manufactured by MetraLabs to TEDIRO's specifications) as a capital medical device. The robot is sold to healthcare facilities (clinics, rehabilitation centers, nursing homes) as the primary hardware platform.
- Software Applications (Medical Device Apps): Therapeutic software applications (THERY UAG, THERY GO) running on the THERY platform. These are certified as medical devices under MDR (EU) and are sold as part of or in connection with the hardware, likely through subscription or licensing models tied to facility deployment.
- Cloud-Based Therapy Management System: Cloud-based therapy management software for configuration, scheduling, documentation, and data export. Provided as a service with server location in Germany, likely on a subscription or per-facility basis.
- Professional Services & Training: Implementation support, training for clinical staff, and ongoing customer success services associated with deploying the robot system in healthcare facilities.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | THERY robot with THERY UAG application (CE-marked medical device for gait training with forearm crutches) |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels5 records
TEDIRO product offering
Product offeringCore offering
TEDIRO develops and sells the THERY mobile robot platform for autonomous therapy and diagnostics in clinical settings. The robot autonomously navigates to the patient, uses on-board cameras and AI to guide exercises and capture gait/balance data without body-worn sensors, and reports objective measurements to therapists. The platform targets physiotherapists in hospitals, rehabilitation centers, geriatric clinics, and nursing homes, and is complemented by modular therapy applications (THERY UAG, THERY GO) and a cloud-based Therapy Management System.
Product overview
TEDIRO offers a platform-plus-applications architecture centered on the THERY mobile robot. The THERY robot serves as the core hardware platform with autonomous navigation capabilities. Multiple software applications run on this platform: THERY UAG provides gait training with forearm crutches (CE marked), while THERY GO enables assistive-device-independent gait training. A proprietary cloud-based Therapy Management System manages robot operations, training plans, and documentation. The company positions itself as a 'Robotics Platform for Therapy and Diagnostics' leveraging physical AI to bring artificial intelligence directly into physical therapy environments.
Differentiator
Problem solved
Functional benefit
Products and services
- THERY Robot Platform Mobile, autonomously navigating therapy and diagnostics robot for clinical use that guides patients through prescribed exercises and performs markerless camera-based gait, balance, and fall-risk assessments. Built for hospitals, rehabilitation clinics, geriatric clinics, and nursing homes to relieve physiotherapist workload and produce objective therapy measurements.
- THERY UAG Application Therapy application module running on the THERY robot platform that delivers guided upper-arm / functional training exercises to patients with autonomous supervision and reporting of exercise performance to clinicians.
- THERY GO Application Therapy and diagnostics application module on the THERY robot platform providing assisted-mobility and fall-risk diagnostics, including gait and balance assessments performed autonomously by the robot.
- Cloud-based Therapy Management System Cloud software companion to the THERY robot that enables therapists to prescribe exercises, configure therapy sessions, visualize patient progress, and document therapy outcomes, integrating with the robot for data-driven clinical workflows.
Quantifiable outcome
- 93% of patients who underwent hip surgery would recommend robot-assisted training to friends and relatives (study at Waldkliniken Eisenberg)
- +5 more outcomes
Companies that use TEDIRO
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles2 records
TEDIRO technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability8 records
Feature6 records
TEDIRO partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and minor.
- DIH-HERO (EU Digital Innovation Hub Healthcare Robotics)coreEU-funded research network for healthcare robotics. TEDIRO received H2020 funding through DIH-HERO COVID19 Response Call (five robot systems deployed in Spain, France, Italy, Germany). Also active in the DIH-HERO GAITREHAB project (2022–2023) for clinical validation across four European hospitals.
- MetraLabs GmbHcoreMetraLabs manufactures the THERY robot platform according to TEDIRO's technical specifications. The company is a pioneer in mobile service robotics with approximately 1,000 systems in use worldwide. MetraLabs provides the proprietary CogniDrive navigation technology. This is a long-term manufacturing and technology partnership fundamental to THERY's hardware.
- Technische Universität Ilmenau (Fachgebiet Neuroinformatik und Kognitive Robotik)coreAcademic research partner contributing expertise in computer vision, AI, and cognitive robotics. Co-developer of core gait analysis and navigation algorithms. Origin of the spin-out relationship. Long-standing collaboration since the ROGER project (2016–2019).
- Waldkliniken EisenbergcoreOne of Germany's largest orthopedic hospitals and key clinical development partner. Provided clinical expertise and real-world testing environment for developing therapeutic applications. Multiple clinical studies conducted (ROGER project, two clinical studies) validating gait training protocols and patient outcomes. Partner in the DIH-HERO GAITREHAB project.
- BioSaxonyminorListed as a development partner on the TEDIRO Partners page. BioSaxony is a network/organization for biotechnology and life sciences companies in Saxony, Germany.
- AKT (Aktionsgemeinschaft zur Förderung von Telemedizin und eHealth in Thüringen)minorListed as a development partner on the TEDIRO Partners page. AKT is a Thuringia-based network for telemedicine and eHealth initiatives.
- ART-KON-TOR (Design Agency)minorMedtech-specialized design agency from Jena commissioned to develop an appealing robot design for the ROLF demonstrator (2021). Contributed industrial design expertise for the robot's physical appearance.
Scale indicators11 records
Recent moves7 records
Expansion highlights7 records
TEDIRO competitors and assessment
Company assessmentDirect peers
- Hocoma (DIH International): Swiss-based pioneer in robotic rehabilitation whose Lokomat, Erigo, and Armeo product lines cover gait and upper-limb therapy. Most direct competitor to TEDIRO in clinic-deployed rehabilitation robotics, with broader product breadth and longer commercial track record.
- Ekso Bionics: Developer of wearable exoskeletons (EksoNR, EksoGT) for walking rehabilitation after stroke, spinal cord injury, and orthopedic surgery. Directly comparable to TEDIRO's THERY platform as a robotic gait-training solution deployed in rehabilitation hospitals.
- ReWalk Robotics: Maker of exoskeleton systems (ReWalk Personal, ReStore) for individuals with lower-limb disabilities and stroke rehabilitation. Comparable clinical positioning in robotic gait restoration and similar hospital and rehab-center go-to-market motion.
Regional players
- CYBERDYNE: Japan-based developer of the HAL (Hybrid Assistive Limb) robot suit for walking support and rehabilitation. Operates in the same robotic gait-therapy category as TEDIRO but is primarily focused on the Japanese and Asian markets.
Emerging players
- Fourier Intelligence: China-based developer of rehabilitation robotics including the RehabHub ecosystem of exoskeleton and end-effector devices for upper and lower-limb therapy. Comparable platform ambition to TEDIRO's hardware-plus-apps model and a potential entrant in European markets.
- Bionik Laboratories: Developer of robotic therapy devices including the InMotion ARM and ARKE lower-body exoskeleton for gait rehabilitation. Targets similar clinical use cases as TEDIRO and competes for the same hospital and rehabilitation-center budgets.
- Reha Technology: Swiss manufacturer of the G-EO System, an end-effector-based gait rehabilitation robot used in clinics. Closely comparable as a clinic-installed robotic gait therapy platform targeting similar orthopedic and neurologic patient populations.
- Mobility Research: US-based maker of LiteGait bodyweight-support gait training devices and related therapy equipment. Adjacent non-robotic competitor used in the same gait therapy workflows where TEDIRO's THERY UAG and THERY GO are deployed.
- Aretech (Recovery Sciences): Australian developer of the ZeroG passive body-weight support system for overground gait and balance training. Competes for the same rehabilitation-center budgets and clinician mindshare as TEDIRO's gait-training applications.
Broad incumbents
- Toyota (Human Support Robot / Welwalk): Large industrial and mobility company that has developed Welwalk WW-2000 robotic gait training system and the HSR humanoid service robot prototype for healthcare settings. Represents a well-capitalized incumbent with potential to expand into TEDIRO's autonomous therapy-robot niche.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
TEDIRO social profiles
Digital presenceTEDIRO compliance and trust
Trust signalCompliance4 records
TEDIRO financial estimates
Financial estimateRevenue estimate
Valuation estimate
TEDIRO leadership team
Management profileNumber of profiles
Profiles2 records
TEDIRO funding detail
Funding detailFunding overview
Funding rounds3 records
Investors5 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
TEDIRO M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about TEDIRO
What does TEDIRO do?
TEDIRO develops and sells the THERY mobile robot platform for autonomous therapy and diagnostics in clinical settings. The robot autonomously navigates to the patient, uses on-board cameras and AI to guide exercises and capture gait/balance data without body-worn sensors, and reports objective measurements to therapists. The platform targets physiotherapists in hospitals, rehabilitation centers, geriatric clinics, and nursing homes, and is complemented by modular therapy applications (THERY UAG, THERY GO) and a cloud-based Therapy Management System.
Is TEDIRO a public or private company?
TEDIRO is a private company. It is classified as venture growth investor backed and is currently operating.
When was TEDIRO founded?
TEDIRO was founded in 2021. It employs 11 to 50 people.
Where is TEDIRO based?
TEDIRO is headquartered in Ilmenau, Germany, in the Europe region.
How does TEDIRO make money?
Four revenue lines are on record. Robot Hardware Sales are the primary driver. The others are software Applications (Medical Device Apps), cloud-Based Therapy Management System and professional Services & Training.
Who are TEDIRO's main competitors?
Direct peers on record are Hocoma (DIH International), Ekso Bionics and ReWalk Robotics. CYBERDYNE is listed as a regional player. Emerging players are Fourier Intelligence, Bionik Laboratories, Reha Technology, Mobility Research and Aretech (Recovery Sciences). Toyota (Human Support Robot / Welwalk) is listed as a broad incumbent.
Does TEDIRO have an API?
No public API is recorded for TEDIRO.
What industry is TEDIRO in?
TEDIRO's product category is Medical Rehabilitation Robotics. Its primary akta.pro industry code is HDAAAIAC, Healthcare & Assistive Robotics, with a secondary code of HLACANAJ, Digital Rehabilitation & Physical Therapy Therapeutics. Its NAICS code is 62134 and its SIC code is 3845.